• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与非酒精性脂肪性肝病及造血系统特征相关的基因变异中的多效性。

Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system.

作者信息

Pirola Carlos Jose, Salatino Adrian, Sookoian Silvia

机构信息

Department of Molecular Genetics and Biology of Complex Diseases, National Scientific and Technical Research Council (CONICET), University of Buenos Aires, Institute of Medical Research (IDIM), Ciudad Autónoma de Buenos Aires C1427ARO, Argentina.

Institute of Medical Research A Lanari, University of Buenos Aires, School of Medicine, Ciudad Autónoma de Buenos Aires, Ciudad Autónoma de Buenos Aires C1427ARO, Argentina.

出版信息

World J Gastroenterol. 2021 Jan 28;27(4):305-320. doi: 10.3748/wjg.v27.i4.305.

DOI:10.3748/wjg.v27.i4.305
PMID:33584064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7852588/
Abstract

Genome-wide association studies of complex diseases, including nonalcoholic fatty liver disease (NAFLD), have demonstrated that a large number of variants are implicated in the susceptibility of multiple traits - a phenomenon known as pleiotropy that is increasingly being explored through phenome-wide association studies. We focused on the analysis of pleiotropy within variants associated with hematologic traits and NAFLD. We used information retrieved from large public National Health and Nutrition Examination Surveys, Genome-wide association studies, and phenome-wide association studies based on the general population and explored whether variants associated with NAFLD also present associations with blood cell-related traits. Next, we applied systems biology approaches to assess the potential biological connection/s between genes that predispose affected individuals to NAFLD and nonalcoholic steatohepatitis, and genes that modulate hematological-related traits-specifically platelet count. We reasoned that this analysis would allow the identification of potential molecular mediators that link NAFLD with platelets. Genes associated with platelet count are most highly expressed in the liver, followed by the pancreas, heart, and muscle. Conversely, genes associated with NAFLD presented high expression levels in the brain, lung, spleen, and colon. Functional mapping, gene prioritization, and functional analysis of the most significant loci ( < 1 × 10) revealed that loci involved in the genetic modulation of platelet count presented significant enrichment in metabolic and energy balance pathways. In conclusion, variants in genes influencing NAFLD exhibit pleiotropic associations with hematologic traits, particularly platelet count. Likewise, significant enrichment of related genes with variants influencing platelet traits was noted in metabolic-related pathways. Hence, this approach yields novel mechanistic insights into NAFLD pathogenesis.

摘要

包括非酒精性脂肪性肝病(NAFLD)在内的复杂疾病的全基因组关联研究表明,大量变异与多种性状的易感性有关——这种现象被称为多效性,目前正通过全表型组关联研究越来越多地进行探索。我们专注于分析与血液学性状和NAFLD相关的变异中的多效性。我们利用从大型公共国民健康与营养检查调查、全基因组关联研究以及基于普通人群的全表型组关联研究中检索到的信息,探讨与NAFLD相关的变异是否也与血细胞相关性状存在关联。接下来,我们应用系统生物学方法来评估使受影响个体易患NAFLD和非酒精性脂肪性肝炎的基因与调节血液学相关性状(特别是血小板计数)的基因之间潜在的生物学联系。我们推断,这种分析将有助于识别将NAFLD与血小板联系起来的潜在分子介质。与血小板计数相关的基因在肝脏中表达最高,其次是胰腺、心脏和肌肉。相反,与NAFLD相关的基因在大脑、肺、脾脏和结肠中呈现高表达水平。对最显著位点(<1×10)的功能图谱绘制、基因优先级排序和功能分析表明,参与血小板计数基因调控的位点在代谢和能量平衡途径中显著富集。总之,影响NAFLD的基因变异与血液学性状,特别是血小板计数,呈现多效性关联。同样,在代谢相关途径中也发现了影响血小板性状的变异相关基因的显著富集。因此,这种方法为NAFLD发病机制提供了新的机制性见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0096/7852588/ce51d35606e6/WJG-27-305-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0096/7852588/e3dd7a07e33a/WJG-27-305-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0096/7852588/8fc0d3184222/WJG-27-305-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0096/7852588/206fbb556937/WJG-27-305-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0096/7852588/b0c79b41c3f8/WJG-27-305-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0096/7852588/14572cef60e1/WJG-27-305-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0096/7852588/31d25df36ba9/WJG-27-305-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0096/7852588/ce51d35606e6/WJG-27-305-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0096/7852588/e3dd7a07e33a/WJG-27-305-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0096/7852588/8fc0d3184222/WJG-27-305-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0096/7852588/206fbb556937/WJG-27-305-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0096/7852588/b0c79b41c3f8/WJG-27-305-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0096/7852588/14572cef60e1/WJG-27-305-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0096/7852588/31d25df36ba9/WJG-27-305-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0096/7852588/ce51d35606e6/WJG-27-305-g007.jpg

相似文献

1
Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system.与非酒精性脂肪性肝病及造血系统特征相关的基因变异中的多效性。
World J Gastroenterol. 2021 Jan 28;27(4):305-320. doi: 10.3748/wjg.v27.i4.305.
2
Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics.非酒精性脂肪性肝病的遗传学:从发病机制到治疗。
Semin Liver Dis. 2019 May;39(2):124-140. doi: 10.1055/s-0039-1679920. Epub 2019 Mar 25.
3
A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects.一项全基因组和表型全基因组关联研究,旨在确定影响血小板计数和体积的遗传变异及其多效性效应。
Hum Genet. 2014 Jan;133(1):95-109. doi: 10.1007/s00439-013-1355-7. Epub 2013 Sep 12.
4
Exploring the interconnected between type 2 diabetes mellitus and nonalcoholic fatty liver disease: Genetic correlation and Mendelian randomization analysis.探讨 2 型糖尿病与非酒精性脂肪性肝病之间的相互关系:遗传相关性和孟德尔随机分析。
Medicine (Baltimore). 2024 May 10;103(19):e38008. doi: 10.1097/MD.0000000000038008.
5
Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer's disease and myocardial infarction.载脂蛋白 E 等位基因特异性变异增加非酒精性脂肪性肝病和肥胖症,但降低阿尔茨海默病和心肌梗死风险。
Hum Mol Genet. 2021 Jul 9;30(15):1443-1456. doi: 10.1093/hmg/ddab096.
6
Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.生物信息学分析揭示了与非酒精性脂肪性肝病和非酒精性脂肪性肝炎相关的新核心基因。
Gene. 2020 Jun 5;742:144549. doi: 10.1016/j.gene.2020.144549. Epub 2020 Mar 14.
7
Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease.核层遗传变异,包括截断的 LAP2,在非酒精性脂肪性肝病的双胞胎和兄弟姐妹中。
Hepatology. 2018 May;67(5):1710-1725. doi: 10.1002/hep.29522. Epub 2018 Mar 24.
8
Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond.朝着非酒精性脂肪性肝病轨迹的遗传预测:PNPLA3 及其以外的进展。
Gastroenterology. 2020 May;158(7):1865-1880.e1. doi: 10.1053/j.gastro.2020.01.053. Epub 2020 Feb 15.
9
Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology.非酒精性脂肪性肝病的遗传途径:系统生物学的见解。
Hepatology. 2020 Jul;72(1):330-346. doi: 10.1002/hep.31229.
10
Genome-Wide Associations Related to Hepatic Histology in Nonalcoholic Fatty Liver Disease in Hispanic Boys.西班牙裔男孩非酒精性脂肪性肝病中与肝脏组织学相关的全基因组关联研究
J Pediatr. 2017 Nov;190:100-107.e2. doi: 10.1016/j.jpeds.2017.08.004. Epub 2017 Sep 14.

引用本文的文献

1
Global Epidemiological Impact of PNPLA3 I148M on Liver Disease.PNPLA3 I148M对肝脏疾病的全球流行病学影响。
Liver Int. 2025 Mar;45(3):e16123. doi: 10.1111/liv.16123. Epub 2024 Oct 7.
2
Population-enriched innate immune variants may identify candidate gene targets at the intersection of cancer and cardio-metabolic disease.富含人群的固有免疫变异体可能在癌症和心脏代谢疾病的交叉点确定候选基因靶点。
Front Endocrinol (Lausanne). 2024 Mar 21;14:1286979. doi: 10.3389/fendo.2023.1286979. eCollection 2023.
3
rs738409 Genetic Variant Inversely Correlates with Platelet Count, Thereby Affecting the Performance of Noninvasive Scores of Hepatic Fibrosis.

本文引用的文献

1
Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology.非酒精性脂肪性肝病的精准医学:遗传学和系统生物学的新治疗见解。
Clin Mol Hepatol. 2020 Oct;26(4):461-475. doi: 10.3350/cmh.2020.0136. Epub 2020 Sep 10.
2
Epigenetics factors in nonalcoholic fatty liver disease.非酒精性脂肪性肝病的表观遗传学因素。
Expert Rev Gastroenterol Hepatol. 2022 Jun;16(6):521-536. doi: 10.1080/17474124.2020.1765772. Epub 2020 Jun 1.
3
Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology.
rs738409 基因变异与血小板计数呈负相关,从而影响肝纤维化无创评分的性能。
Int J Mol Sci. 2023 Oct 10;24(20):15046. doi: 10.3390/ijms242015046.
4
Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response.非酒精性脂肪性肝病的遗传学:免疫应答视角下的风险等位基因作用。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S184-S195. doi: 10.3350/cmh.2022.0318. Epub 2022 Dec 5.
5
PNPLA3 and COVID-19 outcomes: Thinking outside the box might explain the biology behind pleiotropic effects of rs738409 on the immune system.PNPLA3与新冠病毒感染的结果:跳出框框思考或许能解释rs738409对免疫系统多效性作用背后的生物学机制。
Liver Int. 2021 Nov;41(11):2801-2804. doi: 10.1111/liv.15043. Epub 2021 Sep 6.
非酒精性脂肪性肝病的遗传途径:系统生物学的见解。
Hepatology. 2020 Jul;72(1):330-346. doi: 10.1002/hep.31229.
4
Genetic variants that associate with cirrhosis have pleiotropic effects on human traits.与肝硬化相关的遗传变异对人类特征具有多效性影响。
Liver Int. 2020 Feb;40(2):405-415. doi: 10.1111/liv.14321. Epub 2020 Jan 1.
5
Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia.瞬时弹性成像用于肝纤维化筛查:来自欧洲和亚洲六个前瞻性队列的成本效益分析。
J Hepatol. 2019 Dec;71(6):1141-1151. doi: 10.1016/j.jhep.2019.08.019. Epub 2019 Aug 27.
6
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.血小板 GPIbα 是 NASH 及其后续肝癌的介质和潜在的干预靶点。
Nat Med. 2019 Apr;25(4):641-655. doi: 10.1038/s41591-019-0379-5. Epub 2019 Apr 1.
7
Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics.非酒精性脂肪性肝病的遗传学:从发病机制到治疗。
Semin Liver Dis. 2019 May;39(2):124-140. doi: 10.1055/s-0039-1679920. Epub 2019 Mar 25.
8
Review article: shared disease mechanisms between non-alcoholic fatty liver disease and metabolic syndrome - translating knowledge from systems biology to the bedside.综述文章:非酒精性脂肪性肝病和代谢综合征之间的共同疾病机制——将系统生物学知识转化到床边。
Aliment Pharmacol Ther. 2019 Mar;49(5):516-527. doi: 10.1111/apt.15163. Epub 2019 Feb 4.
9
Human-Disease Phenotype Map Derived from PheWAS across 38,682 Individuals.从 38682 个人中得出的 PheWAS 人类疾病表型图谱。
Am J Hum Genet. 2019 Jan 3;104(1):55-64. doi: 10.1016/j.ajhg.2018.11.006. Epub 2018 Dec 29.
10
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.利用多基因功能富集提高 GWAS 效力。
Am J Hum Genet. 2019 Jan 3;104(1):65-75. doi: 10.1016/j.ajhg.2018.11.008. Epub 2018 Dec 27.